Ribomic Inc. (4591.T)
JPY 89.0
(2.3%)
JPY 89.0
(2.3%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -1.11 Billion JPY | 37.5% |
| 2022 | -1.78 Billion JPY | -2.17% |
| 2021 | -1.74 Billion JPY | -41.02% |
| 2020 | -1.23 Billion JPY | -35.63% |
| 2019 | -914 Million JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -257 Million JPY | 10.32% |
| 2023 Q1 | -338.22 Million JPY | -23.6% |
| 2023 Q2 | -243.57 Million JPY | 27.98% |
| 2023 Q4 | -286.58 Million JPY | -15.65% |
| 2023 Q3 | -247.8 Million JPY | -1.74% |
| 2023 FY | -1.11 Billion JPY | 37.5% |
| 2022 Q3 | -584.87 Million JPY | -97.91% |
| 2022 FY | -1.78 Billion JPY | -2.17% |
| 2022 Q4 | -273.63 Million JPY | 53.22% |
| 2022 Q2 | -295.52 Million JPY | 0.0% |
| 2021 FY | -1.74 Billion JPY | -41.02% |
| 2020 FY | -1.23 Billion JPY | -35.63% |
| 2019 FY | -914 Million JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 596.82 Million JPY | 287.023% |
| PRISM BioLab Co.,LTD | -496.86 Million JPY | -124.646% |
| GNI Group Ltd. | 13.1 Billion JPY | 108.515% |
| Linical Co., Ltd. | 725.72 Million JPY | 253.804% |
| Trans Genic Inc. | 89.43 Million JPY | 1348.035% |
| MEDINET Co., Ltd. | -1.42 Billion JPY | 21.723% |
| Soiken Holdings Inc. | -610 Million JPY | -82.98% |
| Cytori Cell Research Institute, Inc. | -772.74 Million JPY | -44.446% |
| AnGes, Inc. | -11.96 Billion JPY | 90.673% |
| OncoTherapy Science, Inc. | -1.12 Billion JPY | 0.411% |
| Nxera Pharma Co., Ltd. | -9.52 Billion JPY | 88.283% |
| Immuno-Biological Laboratories Co., Ltd. | 104.29 Million JPY | 1170.186% |
| NanoCarrier Co., Ltd. | -864.41 Million JPY | -29.127% |
| Carna Biosciences, Inc. | -1.11 Billion JPY | 0.07% |
| CanBas Co., Ltd. | -1.26 Billion JPY | 11.554% |
| D. Western Therapeutics Institute, Inc. | -798.55 Million JPY | -39.776% |
| RaQualia Pharma Inc. | -337.36 Million JPY | -230.856% |
| Chiome Bioscience Inc. | -1.2 Billion JPY | 7.383% |
| Kidswell Bio Corporation | -1.33 Billion JPY | 16.427% |
| PeptiDream Inc. | 6.77 Billion JPY | 116.48% |
| Oncolys BioPharma Inc. | -1.92 Billion JPY | 42.166% |
| SanBio Company Limited | -4.53 Billion JPY | 75.409% |
| Healios K.K. | -3.37 Billion JPY | 66.967% |
| BrightPath Biotherapeutics Co., Ltd. | -1.15 Billion JPY | 3.367% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.39 Billion JPY | 19.901% |
| Delta-Fly Pharma, Inc. | -1.4 Billion JPY | 20.442% |
| StemRIM | -2.07 Billion JPY | 46.233% |
| CellSource Co., Ltd. | 1.22 Billion JPY | 191.379% |
| FunPep Company Limited | -994 Million JPY | -12.293% |
| Kringle Pharma, Inc. | -888.76 Million JPY | -25.59% |
| Stella Pharma Corporation | -760.3 Million JPY | -46.81% |
| TMS Co., Ltd. | -943.25 Million JPY | -18.334% |
| Noile-Immune Biotech Inc. | -775.39 Million JPY | -43.952% |
| Cuorips Inc. | -588.48 Million JPY | -89.672% |
| K Pharma,Inc. | 366.05 Million JPY | 404.923% |
| Takara Bio Inc. | 3 Billion JPY | 137.169% |
| ReproCELL Incorporated | -409.29 Million JPY | -172.712% |
| PhoenixBio Co., Ltd. | 11.06 Million JPY | 10189.424% |
| StemCell Institute Inc. | 413.75 Million JPY | 369.769% |
| Japan Tissue Engineering Co., Ltd. | 144.5 Million JPY | 872.414% |
| CellSeed Inc. | -697.77 Million JPY | -59.964% |